German Cancer Aid, the leading German cancer charity, has asked the German health ministry to stop its anti-smoking advertising campaign ("smoke free") immediately.
The campaign, funded by the tobacco industry, is intended to prevent young people taking up smoking. But a spokesperson for the charity claims that the series of attractive advertisements glamorises smoking rather than deterring people from taking it up.
The advertisements show attractive young people smoking, accompanied by big slogans such as "Smoking soothes" and "Smokers have contacts" and with statements in smaller type such as "Right, but with carcinogenic substances such as arsenic, radon, or tar."
The criticism was supported by delegates at the recent world conference on tobacco and health held in Helsinki. John Seffrin, president of the International Union against Cancer, said it was despicable that a government should take money from tobacco companies that dictate the conditions of an anti-smoking campaign.
Two years ago the German health ministry signed a contract with the Association of Tobacco Industry guaranteeing financial support of €11.8m (£8.3m; $13.4m) over five years. The money must be used solely for campaigns for the prevention of smoking in children and young people. Under the contract the tobacco industry has no influence on the content or style of the campaigns. However, the contract says that "the measures must not discriminate against the tobacco industry, its products and the sale of cigarettes, or criticise adult smokers."
The German health ministry rejects the charity's criticism, pointing out the clause in the contract that sets out the independence of the campaign. Furthermore, a ministry spokeswoman said, the contract has always been made public.
The Federal Centre for Health Education in Cologne, which developed the campaign, said that it was tested on a representative audience before it went public and this showed that the advertisements were not misunderstood and were clearly seen as anti-smoking.
"We have to use attractive means to draw the attention of young people to the advertisements," said Elisabeth Pott, the centre's director.
German government under attack for anti-smoking advertisements
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Bacteria with multiple resistance to antibiotics, until now found only in UK hospitals, may have emerged in the community.
Samples taken from 57 patients, mostly with urinary tract infections, in two parts of the United Kingdom, have shown evidence of Escherichia coli with multiple resistance to drugs.
The findings, reported by the Health Protection Agency, may indicate that resistant bacteria are emerging in the community independently of hospital settings, with significant implications for the way GPs treat urinary tract infections, one of the more common conditions they see.
The agency says that enterobacteriaceae with extended spectrum β lactamases (ESBL) have been found in community acquired infections in two bordering areas of Surrey and in an area of the West Midlands. "This marks a serious development in England, as infections with ESBL-producing bacteria have previously been the preserve of hospitals," says a report on 7 August in CDR Weekly (www.phls.org.uk/publications/ cdr/index.html).
Dr Alan Johnson, clinical scientist with the agency, says that the cause for concern is that the findings, which were recorded at three separate laboratories, may indicate a shift into the community.
"That is a worry because if it is the beginning of a trend, it would make life more complicated for someone with UTI [urinary tract infection] in the community," he said. "It narrows down the treatment options."
"Isolates with these enzymes [extended spectrum β lactamases] are resistant to all the penicillins or cephalosporins that a GP might use, and, on top of this, these particular isolates were resistant also to other standard treatments for UTI, including trimethoprim and the quinolones such as ciprofloxacin," he said.
Scientists at the agency are still investigating, but the early indications are that many of the 57 isolates have a type of enzyme (CTX-M) that has only been recorded in the United Kingdom during the past two years, with the first outbreak associated with hospitals at the beginning of this year.
This enzyme, which breaks down cephalosporins as well as penicillins, is thought to have been acquired by E coli, possibly by a gene transfer, from the obscure Kluyvera species of bacteria. "We have been seeing these enzymes in the last few years in a number of different parts of the world. The present isolates appear to be community associated, although we are now looking at the patients from whom the isolates were taken to see if there is any link with hospitals," says Dr Johnson.
Investigators have so far found some differences between the isolates from the West Midlands and those from Surrey.
"Further investigations into the present isolates and risk factors for infection are under way, but it appears that those from the south east include diverse strains whereas those from the West Midlands are mostly, but not exclusively, clonal," says the report.
Officials warn of multiple drug resistance in the community
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News "Smoking makes you grown up. That's right: your skin, blood vessels in the brain, and arteries age more quickly"
